Novocure Ltd Ord Sh (NVCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 655,353 | 605,220 | 509,338 | 537,840 | 535,031 |
| Cost of Goods | 166,879 | 137,181 | 128,280 | 114,867 | 114,877 |
| Gross Profit | 488,474 | 468,039 | 381,058 | 422,973 | 420,154 |
| Operating Expenses | 643,153 | 638,716 | 614,208 | 513,363 | 465,364 |
| Operating Income | -153,800 | -170,496 | -232,870 | -89,523 | -44,333 |
| Interest Expense | -17,550 | -39,334 | -41,130 | -7,677 | 7,742 |
| Pre-tax Income | -136,250 | -131,162 | -191,740 | -81,846 | -52,075 |
| Income Tax | -23 | 37,465 | 15,303 | 10,688 | 6,276 |
| Net Income Continuous | -136,227 | -168,627 | -207,043 | -92,534 | -58,351 |
| Net Income | $-136,227 | $-168,627 | $-207,043 | $-92,534 | $-58,351 |
| EPS Basic Total Ops | -1.22 | -1.56 | -1.95 | -0.88 | -0.56 |
| EPS Basic Continuous Ops | -1.22 | -1.56 | -1.95 | -0.88 | -0.56 |
| EPS Diluted Total Ops | -1.22 | -1.56 | -1.95 | -0.88 | -0.56 |
| EPS Diluted Continuous Ops | -1.22 | -1.56 | -1.95 | -0.88 | -0.56 |
| EPS Diluted Before Non-Recurring Items | -1.22 | -1.56 | -1.95 | -0.88 | -0.56 |
| EBITDA(a) | $-162,412 | $-184,905 | $-244,985 | $-80,435 | $-30,981 |